Suppr超能文献

从 1 型糖尿病的诊断开始,胰岛自身抗体反应的纵向丧失会随着随访时间的延长而逐渐发生,其决定因素包括低自身抗体滴度、发病早和遗传变异。

The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants.

机构信息

Diabetes and Metabolism, Translational Health Sciences, Bristol Medical School, University of Bristol, Level 2, Learning and Research Building, Southmead Hospital, Bristol BS10 5NB, UK.

出版信息

Clin Exp Immunol. 2022 Dec 15;210(2):151-162. doi: 10.1093/cei/uxac087.

Abstract

The clinical usefulness of post-diagnosis islet autoantibody levels is unclear and factors that drive autoantibody persistence are poorly defined in type 1 diabetes (T1D). Our aim was to characterise the longitudinal loss of islet autoantibody responses after diagnosis in a large, prospectively sampled UK cohort. Participants with T1D [n = 577] providing a diagnosis sample [range -1.0 to 2.0 years] and at least one post-diagnosis sample (<32.0 years) were tested for autoantibodies to glutamate decarboxylase 65 (GADA), islet antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A). Select HLA and non-HLA SNPs were considered. Non-genetic and genetic factors were assessed by multivariable logistic regression models for autoantibody positivity at initial sampling and autoantibody loss at final sampling. For GADA, IA-2A, and ZnT8A, 70.8%, 76.8%, and 40.1%, respectively, remained positive at the final sampling. Non-genetic predictors of autoantibody loss were low baseline autoantibody titres (P < 0.0001), longer diabetes duration (P < 0.0001), and age-at-onset under 8 years (P < 0.01--0.05). Adjusting for non-genetic covariates, GADA loss was associated with low-risk HLA class II genotypes (P = 0.005), and SNPs associated with autoimmunity RELA/11q13 (P = 0.017), LPP/3q28 (P = 0.004), and negatively with IFIH1/2q24 (P = 0.018). IA-2A loss was not associated with genetic factors independent of other covariates, while ZnT8A loss was associated with the presence of HLA A*24 (P = 0.019) and weakly negatively with RELA/11q13 (P = 0.049). The largest longitudinal study of islet autoantibody responses from diagnosis of T1D shows that autoantibody loss is heterogeneous and influenced by low titres at onset, longer duration, earlier age-at-onset, and genetic variants. These data may inform clinical trials where post-diagnosis participants are recruited.

摘要

胰岛自身抗体水平在诊断后的临床应用尚不清楚,1 型糖尿病(T1D)中驱动自身抗体持续存在的因素也尚未明确。我们的目的是在一个大型的、前瞻性采样的英国队列中,描述诊断后胰岛自身抗体反应的纵向丧失。入组的 T1D 患者[577 例]提供了诊断样本[范围-1.0 至 2.0 年]和至少一个诊断后样本(<32.0 岁),并检测了谷氨酸脱羧酶 65(GADA)、胰岛抗原 2(IA-2A)和锌转运体 8(ZnT8A)的自身抗体。考虑了特定的 HLA 和非 HLA SNP。通过多变量逻辑回归模型评估非遗传和遗传因素,用于初始采样时自身抗体阳性和最终采样时自身抗体丧失的预测。对于 GADA、IA-2A 和 ZnT8A,分别有 70.8%、76.8%和 40.1%在最终采样时仍为阳性。自身抗体丧失的非遗传预测因素包括基线自身抗体滴度较低(P<0.0001)、糖尿病病程较长(P<0.0001)和发病年龄<8 岁(P<0.01--0.05)。调整非遗传协变量后,GADA 丧失与低风险 HLA Ⅱ类基因型相关(P=0.005),与自身免疫相关的 RELA/11q13(P=0.017)、LPP/3q28(P=0.004)的 SNP 相关,与 IFIH1/2q24(P=0.018)呈负相关。IA-2A 丧失与独立于其他协变量的遗传因素无关,而 ZnT8A 丧失与 HLA A*24 有关(P=0.019),与 RELA/11q13 呈弱负相关(P=0.049)。这是 T1D 诊断后胰岛自身抗体反应的最大纵向研究,表明自身抗体丧失具有异质性,并且受到发病时低滴度、较长病程、发病年龄较早和遗传变异的影响。这些数据可能为招募诊断后参与者的临床试验提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc5/9750828/9e21b4ba64c5/uxac087f0005.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验